(S (NP (DT This) (NN chapter)) (VP (VBZ presents) (NP (NP (DT a) (NN methodology)) (PP (IN for) (NP (NP (NN diagnosis)) (PP (IN of) (NP (JJ pigmented) (NN skin) (NNS lesions))) (VP (VBG using) (NP (JJ convolutional) (JJ neural) (NNS networks))))))) (. .))
(S (S (NP (DT The) (NN architecture)) (VP (VBZ is) (VP (VBN based) (PP (IN on) (NP (JJ convolu-tional) (JJ neural) (NNS networks)))))) (CC and) (S (NP (PRP it)) (VP (VBZ is) (VP (VBN evaluated) (S (VP (VBG using) (NP (NP (JJ new) (NNP CNN) (NNS models)) (CONJP (RB as) (RB well) (IN as)) (S (NP (NP (JJ re-trained) (NN modification)) (PP (IN of) (NP (JJ pre-existing) (NNP CNN) (NNS models)))) (VP (VBD were) (VP (VBN used)))))))))) (. .))
(S (NP (DT The) (JJ experi-mental) (NNS results)) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (NP (NNP CNN) (NNS models)) (VP (VBN pre-trained) (PP (IN on) (NP (JJ big) (NNS datasets))) (PP (IN for) (NP (JJ gen-eral) (JJ purpose) (NN image) (NN classification))))) (SBAR (WHADVP (WRB when)) (S (VP (JJ re-trained) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB identify) (NP (JJ skin) (NN le-sion) (NNS types)))))))))) (VP (VBP offer) (NP (ADJP (JJR more) (JJ accurate)) (NNS results)) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (TO to) (NP (NP (VB convolutional) (JJ neural) (NN network) (NNS models)) (VP (VBN trained) (ADVP (RB explicitly)) (PP (IN from) (NP (DT the) (NN dermatoscopic) (NNS images))))))))))))) (. .))
(S (NP (DT The) (JJS best) (NN performance)) (VP (VBD was) (VP (VBN achieved) (PP (IN by) (S (VP (VBG re-training) (NP (NP (DT a) (JJ modified) (NN version)) (PP (IN of) (NP (NNP ResNet-50) (JJ convolutional) (JJ neural) (NN network)))) (PP (IN with) (NP (NP (NN accuracy)) (ADJP (JJ equal) (PP (TO to) (NP (CD 93.89) (NN %))))))))))) (. .))
(S (NP (NP (NN Analysis)) (PP (IN on) (NP (JJ skin) (NN lesion) (NN pathology) (NN type)))) (VP (VBD was) (ADVP (RB also)) (VP (VBN performed) (PP (IN with) (S (NP (NP (NN classification) (NN accuracy)) (PP (IN for) (NP (NP (NN melanoma)) (CC and) (NP (NN basal) (NN cell) (NN carcinoma))))) (VP (VBG being) (ADJP (JJ equal) (PP (TO to) (NP (NP (NP (CD 79.13) (NN %)) (CC and) (NP (CD 82.88) (NN %))) (, ,) (ADVP (RB respectively)))))))))) (. .))
